<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>712074e9-4038-4198-bfd0-f8ae8c07a72b</id>
  <name>Iloprost for Frostbite Order Group</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~712074e9-4038-4198-bfd0-f8ae8c07a72b~NAME~Iloprost for Frostbite Order Group}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #1&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Indication: Treatment for SEVERE Frostbite (Grade 2 or higher) if less than 72 hours since rewarming and no episode of refreezing.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;lloprost is obtained from Health Canada&apos;s Special Access Program (SAP) and may not be readily available at all sites.&lt;br&gt;&amp;nbsp;&lt;br&gt;Benefits of the use of iloprost in frostbite is controversial&lt;br&gt;&amp;nbsp;&lt;br&gt;Repeat infusion DAILY for a total of 5 DOSES.&lt;br&gt;&amp;nbsp;&lt;br&gt;Dosage requires adjustment in hepatic impairment. Use caution in renal impairment.&lt;br&gt;&amp;nbsp;&lt;br&gt;Each infusion is run for a maximum of 6 hours. If first iloprost infusion starts at 1800 or earlier, order all subsequent infusions to start at 0800 hours on the following days. If the first infusion starts 1800 or later, schedule second infusion 8 hours following completion of first infusion (may be scheduled on the same day as first DOSE). E.g. if first iloprost infusion is started at 2100 and completed at 0500h, order the second infusion to start at 1300 and subsequent infusions at 0800 hours. Prescriber is responsible for adjusting all administration times.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;- &lt;u&gt;&lt;strong&gt;Guidelines for Frostbite Grading (page 6)&lt;/strong&gt;&lt;/u&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;(URL:&amp;nbsp;http://ahsweb.ca/HEE/Care_of_the_Adult_with_Severe_Frostbite)&lt;/p&gt;&lt;p&gt;- &lt;u&gt;&lt;strong&gt;Link for SAP access&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;p&gt;(URL:&amp;nbsp;https://ahsweb.ca/HEE/Health_Canada_Special_Access_Program_SAP)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 1. Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 6 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first infusion. Prescriber may need to adjust start time.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first iloprost infusion. Prescriber may need to adjust start time.&amp;nbsp;&lt;br&gt;Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 6 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 3. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Infusion DOSE 4. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 5. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;br&gt;Continue infusion for maximum of 6 hours regardless of the infusion rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;40 to 50 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 1. Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 8 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first infusion. Prescriber may need to adjust start time.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first iloprost infusion. Prescriber may need to adjust start time.&amp;nbsp;&lt;br&gt;Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 8 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 3. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 4. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 5. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;br&gt;Continue infusion for maximum of 6 hours regardless of the infusion rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;51 to 74 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Infusion DOSE 1. Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 10 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first infusion. Prescriber may need to adjust start time.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting today, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting tomorrow at 08:00, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;Infusion DOSE 2 must start at least 8 hours after completion of the first iloprost infusion. Prescriber may need to adjust start time.&amp;nbsp;&lt;br&gt;Start infusion at 2 microgram/hour and increase infusion rate by 2 microgram/hour every 30 minutes to max of 10 microgram/hour.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;&lt;span style=&quot;font-size:12px&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting tomorrow at 08:00, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+2 days at 08:00, For 6 hours&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 3. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+2 days at 08:00, For 6 hours&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+3 days at 08:00, For 6 hours #1&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 4. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+3 days at 08:00, For 6 hours #1&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+4 days at 08:00, For 6 hours #2&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;Infusion DOSE 5. Infuse at maximum rate tolerated on DOSE 1 and 2.&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;During the administration of iloprost monitor blood pressure and heart rate every 15 minutes for two hours, then decrease frequency to every 30 minutes. If headache, tachycardia (HR greater than 100 bpm), palpitations, hypotension (systolic BP less than 90 mmHg), nausea, vomiting or facial flushing present, decrease infusion rate by 2 microgram/hour and re-assess 30 minutes later. Notify MRHP if side effects persist.&amp;nbsp;&lt;br&gt;Continue infusion for maximum of 6 hours regardless of the infusion rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style=&quot;font-size:12px&quot;&gt;&lt;span style=&quot;font-family:Helvetica&quot;&gt;**Continue infusion for MAXIMUM of 6 HOURS regardless of the infusion rate.**&lt;br&gt;Note: There may be extra iloprost in the infusion bag and IV tubing. Please discard after the maximum 6 hour infusion is complete.&lt;br&gt;CAUTION: High Alert Medication.&lt;br&gt;This is a Formulary Restricted drug. The restriction criteria are listed at the top of the order composer. Does the patient meet these criteria? Yes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+4 days at 08:00, For 6 hours #2&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;75 kg and greater&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Iloprost (for grade 2-4 frostbite if within less than 72 hours since rewarming)">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="40 to 50 kg">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting today, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #1"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #2"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #3"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-6 mcg/hr (10-30 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="51 to 74 kg">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting today, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting tomorrow at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #1"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+2 days at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #2"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+3 days at 0800, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #3"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-8 mcg/hr (10-40 mL/hr), intravenous, titrated, Starting S+4 days at 0800, For 6 hours"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #1"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="75 kg and greater">
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting today, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting tomorrow at 08:00, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #1"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+2 days at 08:00, For 6 hours"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #3"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+3 days at 08:00, For 6 hours #1"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by #2"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="016746fc-7bc7-4337-b78e-087590453a31" concept_name="PHARM iloprost infusion Order" max="1" path="/items" name="iloprost infusion; 2-10 mcg/hr (10-50 mL/hr), intravenous, titrated, Starting S+4 days at 08:00, For 6 hours #2"/>
      <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
    </Item>
    <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>